Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey.

C. Compher | L. Ellegård | A. Van Gossum | R. Lloyd | G. Olveira | L. Czakó | E. Steiger | S. Schneider | F. Guglielmi | B. Chapman | Ruth Hodgson | M. Serlie | L. Santarpia | M. Taus | M. Mundi | H. Rasmussen | A. Crivelli | K. Szczepanek | S. Lal | Trevor R Smith | N. Youssef | F. Izbéki | A. Serralde-Zúñiga | J. Bataille | A. Sanz-París | G. Wanten | N. Wyer | M. Stroud | M. Theilla | R. Thibault | P. Jeppesen | Ž. Krznarić | M. Kunecki | L. Pironi | E. Nardi | D. Busni | L. Billiauws | F. Joly | J. Arends | N. Virgili | C. Chambrier | A. Abraham | E. Osland | G. Kėkštas | D. Seguy | N. Keane | S. Cooper | V. Boehm | C. Garde | F. Poullenot | L. Alfonsi | N. R. Kozjek | P. Orlandoni | E. Schafer | S. di Caro | C. Cuerda | M. Taylor | L. Gillanders | Toma Molnar | A. Sasdelli | N. Burch | P. Matras | A. Zmarzły | J. P. Suárez-Llanos | A. D. Won Lee | M. O'Callaghan | K. Lasenby | A. Z. Murillo | Siobhan Wallin | G. Brillanti | N. Regano | P. Patel | K. Matysiak | L. Jones | M. Díez | M. Doitchinova-Simeonova | Denise Jezerski | V. Bertasi | P. Sahin | U. Aimasso | M. Bueno | C. Brandt | S. Zeraschi | A. Jukes | J. Daniels | Jian Wu | C. Spaggiari | Luisa Masconale | C. Pither | C. Jonker | A. Forbes | Gábor Udvarhelyi | Andre D. Won Lee | Mª Estrella Petrina Jáuregui | H. S. Muñiz | Andre Dong Won Lee | Mihaly Zsilak-Urban | Merlo F. Dario | S. Lidia | Ma Estrella Petrina Jáuregui | Sarah-Jane Nelson Hughes | Gerda Garside | Reena Parmar | T. Smith | M. Jauregui | H. Rasmussen

[1]  L. Pironi,et al.  Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort. , 2021, Clinical nutrition.

[2]  F. Joly,et al.  The new place of enterohormones in intestinal failure , 2020, Current opinion in clinical nutrition and metabolic care.

[3]  A. Van Gossum,et al.  ESPEN guideline on home parenteral nutrition. , 2020, Clinical nutrition.

[4]  A. Forbes,et al.  Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey. , 2020, Clinical nutrition.

[5]  A. Forbes,et al.  Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure , 2020, Gut.

[6]  D. Quilliot,et al.  Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study. , 2019, Clinical nutrition.

[7]  L. Pironi.  Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature. , 2019, JPEN. Journal of parenteral and enteral nutrition.

[8]  P. Jeppesen.  The Long Road to the Development of Effective Therapies for the Short Gut Syndrome: A Personal Perspective , 2019, Digestive Diseases and Sciences.

[9]  A. Forbes,et al.  An international study of the quality of life of adult patients treated with home parenteral nutrition. , 2019, Clinical nutrition.

[10]  L. Billiauws,et al.  Emerging treatments for short bowel syndrome in adult patients , 2019, Expert review of gastroenterology & hepatology.

[11]  M. Soop,et al.  Examining the pathophysiology of short bowel syndrome and glucagon-like peptide 2 analogue suitability in chronic intestinal failure: experience from a national intestinal failure unit , 2018, European Journal of Clinical Nutrition.

[12]  D. Seidner,et al.  Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure. , 2017, Gastroenterology.

[13]  S. Tribler,et al.  Single-Center, Adult Chronic Intestinal Failure Cohort Analyzed According to the ESPEN-Endorsed Recommendations, Definitions, and Classifications , 2017, JPEN. Journal of parenteral and enteral nutrition.

[14]  A. Forbes,et al.  Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey. , 2017, Clinical nutrition.

[15]  L. Pironi.  Definitions of intestinal failure and the short bowel syndrome. , 2016, Best practice & research. Clinical gastroenterology.

[16]  A. Van Gossum,et al.  ESPEN guidelines on chronic intestinal failure in adults. , 2016, Clinical nutrition.

[17]  P. Jeppesen.  Teduglutide for the treatment of short bowel syndrome. , 2013, Drugs of today.

[18]  A. Amiot,et al.  Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. , 2013, Clinical nutrition.

[19]  A. Van Gossum,et al.  Monitoring of patients on home parenteral nutrition (HPN) in Europe: a questionnaire based study on monitoring practice in 42 centres. , 2006, Clinical nutrition.

[20]  J. Woodward,et al.  Guidelines for management of patients with a short bowel , 2006, Gut.

[21]  T J Cole,et al.  Small intestinal length: a factor essential for gut adaptation. , 1991, Gut.

[22]  B. M. Underhill.  Intestinal Length in Man , 1955, British medical journal.

[23]  T. Scheike,et al.  Differences in methodology impact estimates of survival and dependence on home parenteral support of patients with nonmalignant short bowel syndrome. , 2019, The American journal of clinical nutrition.